Business ❯ Healthcare ❯ Pharmaceutical Industry

Drug Development

Clinical Trials Women's Health GLP-1 Medicines Precision Medicine GLP-1 Weight-Loss Drugs Obesity Treatments Investor Relations Market Dynamics Peptide Drugs Market Competition Weight-Loss Treatments GLP-1 Drugs Innovative Therapies Antibodies Oncology Pipeline Biosimilars Pfizer Products Patent Expiration Transparency in Drug Approval Cancer Medications

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Early launch scrutiny underscores a long-term push into cancer treatments alongside obesity care.

Ligand to Buy XOMA Royalty for $739 Million

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy